New Cancer Immunotherapy in the Making Thanks to Donnelly Centre's Antibody Engineering Technology

Researchers Seek to Make Blood Stem Cell Transplants Available to More Patients

Director Brenda Andrews to Help Lead Canada’s Largest Health Research Funding Body

Recent publications

Global landscape of cell envelope protein complexes in Escherichia coli. Nat Biotech 2017 Nov 27.

A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Mol Cell 2017 Oct 19.

Functional annotation of chemical libraries across diverse biological processes. Nat Chem Bio 2017 July 24.

Regulatory Expansion in Mammals of Multivalent hnRNP Assemblies that Globally Control Alternative Splicing. Cell. 2017 Jul 13.

Driving Innovation in Medicine

Discoveries made in basic science are the foundation for all future progress in medicine. Emerging genomic and stem cell technologies hold the promise of personalized treatments that are tailored to patient’s unique genetic makeup and physiology. Through our collaborative approach, the Donnelly Centre is in a position to make breakthrough discoveries in biology and to lead the world in advancing personalized medicine.

Your gift to the Donnelly Centre allows researchers to explore new and innovative ideas that will transform our understanding of biology. It supports discovery that will unearth the cause of human disease, advance diagnosis and disease detection, create personalized therapies, and reverse injury through regenerative medicine.

View our 2016 Annual Report to learn about our last year's accomplishments

Back to Top